官方服务：
资源简介：
Mody related precision therapy
应用场景：
创建时间：
2021-07-07
相关数据集
Engineering Peptide Self-Assembly for Glucose-Responsive Glucagon Delivery
Stimuli-responsive materials are gaining traction in precise drug delivery, especially for diabetes management. Intensified insulin treatment can cause acute hypoglycemia (BGL < 70 mg/dL), leading
DataCite Commons2024-11-11 更新90
Additional file 2: Figure S1. of Comprehensive genomic analysis identifies pathogenic variants in maturity-onset diabetes of the young (MODY) patients in South India
Box plot showing (a) fasting plasma glucose, (b) fasting insulin, (c) C-peptide fasting, (d) C-peptide stimulated and (e) creatinine in MODY and control samples. The median value is shown as a line wi
Figshare2018-02-14 更新50
DataSheet_1_Gut Microbial Signatures for Glycemic Responses of GLP-1 Receptor Agonists in Type 2 Diabetic Patients: A Pilot Study.pdf
BackgroundsGlucagon-like peptide-1 receptor agonist (GLP-1 RA) is probably one of more effective antidiabetic agents in treatment of type 2 diabetes mellitus (T2D). However, the heterogenicity in resp
NIAID Data Ecosystem50
ena-DATASET-Genentech-23-01-2018-21:18:03:506-24 - samples
We performed whole genome, whole or targeted exome sequencing for 289 individuals from India. This included 152 clinically diagnosed MODY and 137 control samples. Whole genome libraries were construct
NIAID Data Ecosystem70
Variation in the Glucose Transporter gene SLC2A2 is associated with glycaemic response to metformin
Metformin is the first-line antidiabetic drug with over 100 million users worldwide, yet its mechanism of action remains unclear1. Here the Metformin Genetics (MetGen) Consortium reports a three-stage
NIAID Data Ecosystem50
